Transduced K7M2 cells (A). Metastasis area (B) and number (C

Transduced K7M2 cells (A). Metastasis area (B) and number (C) in the lung tissue were evaluated. Results are expressed as mean 6 s.d. (n = 9 animals per group). *P,0.05 vs shControl. Proposed model in which FHL2 buy ML 281 silencing using shFHL2 in murine osteosarcoma cells attenuates Wnt/b-catenin signaling and reduces the expression of Wnt5a and Wnt10b and possibly other FHL2 target genes in the tumors, resulting in decreased osteosarcoma cell growth, invasiveness and tumorigenesis in vivo (D). doi:10.1371/journal.pone.0055034.gosteosarcoma cells [27], all obtained from ATCC (Rockville, MD, USA). Normal human osteoblasts (IHNC) were obtained from human neonatal calvaria, and murine C3H10T1/2 and MC3T3E1 cells were from ATCC. The cells were cultured in DMEM (Invitrogen Corporation, Paisley, Scotland) in the presence of 10 heat inactivated FCS, 1 L-glutamine and penicillin/streptomy-cin (10,000 U/ml and 10,000 mg/ml, respectively) with medium change every 2? days. For FHL2 silencing, lentiviral particules containing shRNA directed against mouse FHL2 or a control shRNA that does not recognize mouse FHL2 were used according to the manufacturer recommendations (Santa Cruz Biotechnology, CA, USA).FHL2 Silencing Reduces Osteosarcoma TumorigenesisCell Proliferation AssayFor cell proliferation assay, K7M2 cells were seeded at 36103 cells/cm2 and cell number was evaluated by cell counting. DNA replication was evaluated using a BrdU ELISA assay (GE Healthcare, Buckinghamshire, UK) as previously Octapressin described [52]. Cells were treated with Wnt3a conditioned medium (CM) obtained as described previously [19] or human recombinant FGF-2 (Peprotech Neuilly-Sur-Seine, France) at the indicated time point.Cell Death AssaysDNA fragmentation was detected using TUNEL staining and effector caspases activity was determined using Ac-DEVD-pNA as substrate (Alexis Biochemicals, CA, USA) [53].actin (1/2000; Sigma-Aldrich, St Quentin Fallavier, France) or mouse anti-p84 (1/1000; Abcam) antibodies. Membranes were then incubated with appropriate HRP-conjugated secondary antibody (1/20,000). The signals were visualized with enhanced chemiluminescence western blotting detection reagent (Immunstar chemiluminescent kit, BioRad, Marnes-la-Coquette, France) and autoradiographic film (X-OMAT-AR, Eastman Kodak Company, Rochester, NY, USA). Densitometric analysis using QuantityOne software (BioRad) was performed 15857111 following digital scanning (Agfa, Japan). Representative images of immunoblots are shown.ImmunocytochemistryFor immunocytochemistry, cells were fixed with 4 PFA in PBS for 10 min at 4uC, washed twice with PBS, permeabilized with 0.025 Triton X-100 for 5 min and blocked with 3 BSA in PBS for 15 minutes at room temperature. Cells were incubated overnight at 4uC with anti-b-catenin antibody (Santa Cruz) used at 1:100 dilution, then incubated with a secondary antibody (goat anti-rabbit conjugated to Cy3; Beckman Coulter, Villepinte, France). Cover glasses were viewed using apotome fluorescence microscopy (Carl Zeiss, Jena, Germany).Cell Invasion and Migration AssaysWounding assay was performed according to the manufacturer’s instructions (Ibidi, BioValley, Marne la Vallee, France). ?Recovery of the denuded area was computerized using an inverted microscope (Leica, Cambridge, UK). Cell migration and invasion were determined in the modified Boyden’s chamber assay, as described previously [52].b-catenin Reporter Assayb-catenin transcriptional activity was determined by Firefly and Ren.Transduced K7M2 cells (A). Metastasis area (B) and number (C) in the lung tissue were evaluated. Results are expressed as mean 6 s.d. (n = 9 animals per group). *P,0.05 vs shControl. Proposed model in which FHL2 silencing using shFHL2 in murine osteosarcoma cells attenuates Wnt/b-catenin signaling and reduces the expression of Wnt5a and Wnt10b and possibly other FHL2 target genes in the tumors, resulting in decreased osteosarcoma cell growth, invasiveness and tumorigenesis in vivo (D). doi:10.1371/journal.pone.0055034.gosteosarcoma cells [27], all obtained from ATCC (Rockville, MD, USA). Normal human osteoblasts (IHNC) were obtained from human neonatal calvaria, and murine C3H10T1/2 and MC3T3E1 cells were from ATCC. The cells were cultured in DMEM (Invitrogen Corporation, Paisley, Scotland) in the presence of 10 heat inactivated FCS, 1 L-glutamine and penicillin/streptomy-cin (10,000 U/ml and 10,000 mg/ml, respectively) with medium change every 2? days. For FHL2 silencing, lentiviral particules containing shRNA directed against mouse FHL2 or a control shRNA that does not recognize mouse FHL2 were used according to the manufacturer recommendations (Santa Cruz Biotechnology, CA, USA).FHL2 Silencing Reduces Osteosarcoma TumorigenesisCell Proliferation AssayFor cell proliferation assay, K7M2 cells were seeded at 36103 cells/cm2 and cell number was evaluated by cell counting. DNA replication was evaluated using a BrdU ELISA assay (GE Healthcare, Buckinghamshire, UK) as previously described [52]. Cells were treated with Wnt3a conditioned medium (CM) obtained as described previously [19] or human recombinant FGF-2 (Peprotech Neuilly-Sur-Seine, France) at the indicated time point.Cell Death AssaysDNA fragmentation was detected using TUNEL staining and effector caspases activity was determined using Ac-DEVD-pNA as substrate (Alexis Biochemicals, CA, USA) [53].actin (1/2000; Sigma-Aldrich, St Quentin Fallavier, France) or mouse anti-p84 (1/1000; Abcam) antibodies. Membranes were then incubated with appropriate HRP-conjugated secondary antibody (1/20,000). The signals were visualized with enhanced chemiluminescence western blotting detection reagent (Immunstar chemiluminescent kit, BioRad, Marnes-la-Coquette, France) and autoradiographic film (X-OMAT-AR, Eastman Kodak Company, Rochester, NY, USA). Densitometric analysis using QuantityOne software (BioRad) was performed 15857111 following digital scanning (Agfa, Japan). Representative images of immunoblots are shown.ImmunocytochemistryFor immunocytochemistry, cells were fixed with 4 PFA in PBS for 10 min at 4uC, washed twice with PBS, permeabilized with 0.025 Triton X-100 for 5 min and blocked with 3 BSA in PBS for 15 minutes at room temperature. Cells were incubated overnight at 4uC with anti-b-catenin antibody (Santa Cruz) used at 1:100 dilution, then incubated with a secondary antibody (goat anti-rabbit conjugated to Cy3; Beckman Coulter, Villepinte, France). Cover glasses were viewed using apotome fluorescence microscopy (Carl Zeiss, Jena, Germany).Cell Invasion and Migration AssaysWounding assay was performed according to the manufacturer’s instructions (Ibidi, BioValley, Marne la Vallee, France). ?Recovery of the denuded area was computerized using an inverted microscope (Leica, Cambridge, UK). Cell migration and invasion were determined in the modified Boyden’s chamber assay, as described previously [52].b-catenin Reporter Assayb-catenin transcriptional activity was determined by Firefly and Ren.